Leleu X - Search Results

1

Response to pneumococcal vaccination in multiple myeloma.

Renaud L, Schraen S, Fouquet G, Guidez S, Demarquette H, Nudel M, Cayssials E, Bories C, Herbaux C, Systchenko T, Faucompré JL, Machet A, Sabirou F, Levy A, Bobin A, Richez V, Moya N, Gruchet C, Desmier D, van de Wyngaert Z, Carpentier B, Manier S, Facon T, Harding S, Leleu X. Renaud L, et al. Among authors: leleu x. Cancer Med. 2019 Jul;8(8):3822-3830. doi: 10.1002/cam4.2253. Epub 2019 May 30. Cancer Med. 2019. PMID: 31145552 Free PMC article.

2

Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapy.

Moreau P, Facon T, Leleu X, Morineau N, Huyghe P, Harousseau JL, Bataille R, Avet-Loiseau H; Intergroupe Francophone du Myélome. Moreau P, et al. Among authors: leleu x. Blood. 2002 Sep 1;100(5):1579-83. doi: 10.1182/blood-2002-03-0749. Blood. 2002. PMID: 12176874 Free article.

3

HLA-G and lymphoproliferative disorders.

Amiot L, Le Friec G, Sebti Y, Drénou B, Pangault C, Guilloux V, Leleu X, Bernard M, Facon T, Fauchet R. Amiot L, et al. Among authors: leleu x. Semin Cancer Biol. 2003 Oct;13(5):379-85. doi: 10.1016/s1044-579x(03)00029-4. Semin Cancer Biol. 2003. PMID: 14708718 Review.

4

Prognostic value of urinary pyridinium crosslinks and their derivatives in multiple myeloma.

Samani KK, Brazier M, Mathiot C, Kamel S, Jamart J, Jaubert J, Blanc M, Azaïs I, Facon T, Leleu X. Samani KK, et al. Among authors: leleu x. Ann Hematol. 2005 Jan;84(1):19-24. doi: 10.1007/s00277-004-0937-9. Epub 2004 Aug 25. Ann Hematol. 2005. PMID: 15338198

5

Evaluation of gemcitabine in relapsed or refractory multiple myeloma.

Leleu X, Troncy J, Bouafia F, Michallet M, Facon T, Dumontet C. Leleu X, et al. Haematologica. 2004 Nov;89(11):ELT15. Haematologica. 2004. PMID: 15533848 Clinical Trial. No abstract available.

6

Abnormal cytogenetics and significant bone marrow plasmacytosis are predictive of early progression and short survival in patients with low tumor mass asymptomatic multiple myeloma.

Depil S, Leleu X, Micol JB, Berthon C, Laï JL, Bauters F, Quesnel B, Facon T. Depil S, et al. Among authors: leleu x. Leuk Lymphoma. 2004 Dec;45(12):2481-4. doi: 10.1080/10428190412331283224. Leuk Lymphoma. 2004. PMID: 15621764

7

Evaluation and prognostic value of serum osteoprotegerin in multiple myeloma.

Depil S, Mathiot C, Leleu X, Moreau AS, Faucompré JL, Hennache B, Bauters F, Bataille R, Facon T. Depil S, et al. Among authors: leleu x. Br J Haematol. 2005 Jun;129(5):706-7. doi: 10.1111/j.1365-2141.2005.05518.x. Br J Haematol. 2005. PMID: 15916694 Free article. No abstract available.

8

Total soluble HLA class I and soluble HLA-G in multiple myeloma and monoclonal gammopathy of undetermined significance.

Leleu X, Le Friec G, Facon T, Amiot L, Fauchet R, Hennache B, Coiteux V, Yakoub-Agha I, Dubucquoi S, Avet-Loiseau H, Mathiot C, Bataille R, Mary JY; Intergroupe Francophone du Myélome. Leleu X, et al. Clin Cancer Res. 2005 Oct 15;11(20):7297-303. doi: 10.1158/1078-0432.CCR-05-0456. Clin Cancer Res. 2005. PMID: 16243800

9

[Treatment of multiple myeloma].

Terriou L, Leleu X, Yakoub-Agha I. Terriou L, et al. Among authors: leleu x. Bull Cancer. 2006 Jan;93(1):101-6. Bull Cancer. 2006. PMID: 16455512 Free article. Review. French.

10

[Prognostic factors and new treatments of multiple myeloma].

Leleu X, Coiteux V, Facon T. Leleu X, et al. Rev Prat. 2006 Jan 15;56(1):31-9. Rev Prat. 2006. PMID: 16548247 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

383 results

Search Page